A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Roswell Park Cancer Institute
Institute of Hematology & Blood Diseases Hospital, China
Prelude Therapeutics
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Thomas Jefferson University
Takeda
Massachusetts General Hospital
Janssen Research & Development, LLC
Massachusetts General Hospital
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Novartis
Thomas Jefferson University
M.D. Anderson Cancer Center